Spots Global Cancer Trial Database for Skin Biopsies in Chemotherapy-Induced Neuropathy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Skin Biopsies in Chemotherapy-Induced Neuropathy
Official Title: Skin Biopsies in Chemotherapy-induced Neuropathy
Study ID: NCT00956033
Interventions
Study Description
Brief Summary: Neuropathy is a common side effect of chemotherapeutics used for the treatment of multiple myeloma, including vincristine, thalidomide and bortezomib. The neuropathy induced by these drugs is often preferentially small fiber. Small fiber neuropathies are difficult to diagnose and quantify using conventional electromyography. Determining intra-epidermal nerve fiber density (IENFD) in skin biopsies from diabetes and AIDS patients has been shown to be a more sensitive and more specific ancillary investigation to establish the diagnosis of small fiber neuropathy. In this study the investigators aim to establish the sensitivity of IENFD measurements in skin biopsies from patients with multiple myeloma treated with bortezomib.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Erasmus MC, Centrumlocatie en Daniel den Hoed, Rotterdam, Zuid-Holland, Netherlands
Contact Details
Name: Joost L Jongen
Affiliation: Erasmus Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
